Search Results

Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®).

• Authors : Sirks, Marc J.; Subhi, Yousif; Rosenberg, Noa

• Source: Ophthalmology & Therapy; Jul2024, Vol. 13 Issue 7, p1821-1831, 11p

Record details

Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®).

• Authors : Sirks, Marc J.; Subhi, Yousif; Rosenberg, Noa

Subjects: POLYPOIDAL choroidal vasculopathy; SCARCITY; EYE careNETHERLANDSEUROPEAN Union

• Source: Ophthalmology & Therapy; Jul2024, Vol. 13 Issue 7, p1821-1831, 11p

Record details

Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells.

• Authors : Wang, Xue-Wei; Yang, Zi-Yi; Li, Ting

• Source: Molecular Biotechnology; Sep2024, Vol. 66 Issue 9, p2558-2568, 11p

Record details

Extrusion/Inkjet Printing of Verteporfin-Loaded Bilayer Skin Substitutes for Wound Healing and Structure Reconstruction.

• Authors : Jiao, Tian; Zhou, Ruilu; Jiao, Junrong

• Source: Journal of Bionic Engineering; Nov2024, Vol. 21 Issue 6, p2969-2984, 16p

Record details

In vitro and in vivo Evaluation of Antifibrotic Properties of Verteporfin in a Composition of a Collagen Scaffold.

• Authors : Rogovaya, Olga S.; Abolin, Danila S.; Cherkashina, Olga L.

Subjects: SKIN regeneration; COLLAGEN; CONTRACTILE proteins

• Source: Biochemistry (00062979); May2024, Vol. 89 Issue 5, p942-957, 16p

Record details

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

• Authors : Huggett, M T¹; Jermyn, M²; Gillams, A³

Subjects: *PANCREATIC cancer; *VERTEPORFIN; *PHOTODYNAMIC therapy

• Source: British Journal of Cancer. 4/1/2014, Vol. 110 Issue 7, p1698-1704. 7p. 1 Color Photograph, 2 Black and White Photographs, 2 Charts, 2 Graphs.

Record details

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization.

• Authors : Hu, Yu-Chen¹; Chen, Yi-Ling¹; Chen, Yen-Chih^1,2,3

Subjects: *VERTEPORFIN; *PHOTODYNAMIC therapy; *FOLLOW-up studies (Medicine)

• Source: Scientific Reports. 6/24/2021, Vol. 11 Issue 1, p1-8. 8p.

Record details

Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

• Authors : Rinaldi, M.; Semeraro, F.; Chiosi, F.

Subjects: MYOPIA treatment; COMBINATION drug therapy; VERTEPORFIN

• Source: Graefe's Archive of Clinical & Experimental Ophthalmology; Mar2017, Vol. 255 Issue 3, p529-539, 11p

Record details

Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression.

• Authors : Condurat, Alexandra-Larisa; Aminzadeh-Gohari, Sepideh; Malnar, Mirjana

Subjects: YAP signaling proteins; CELL survival; NEUROBLASTOMAUNITED States. Food & Drug Administration

• Source: Scientific Reports; 3/7/2023, Vol. 13 Issue 1, p1-15, 15p

Record details

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma.

• Authors : Wang, Xue-Wei; Zhao, Rong; Yang, Zi-Yi

Subjects: SQUAMOUS cell carcinoma; PACLITAXEL; ESOPHAGEAL cancer

• Source: Journal of Cancer Research & Clinical Oncology; Aug2023, Vol. 149 Issue 10, p7703-7716, 14p

Record details